Valuation: Senzime AB

Market Cap 604M 63.84M 54.68M 51.16M 46.84M 87.9M 6.11B 89.06M 236M 3.07B 240M 234M 10.15B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 604M 63.84M 54.68M 51.16M 46.84M 87.9M 6.11B 89.06M 236M 3.07B 240M 234M 10.15B EV / Sales 2026 *
4.73x
EV / Sales 2027 * 2.96x
Free-Float
40.74%
Yield 2026 *
-
Yield 2027 * -
1 day-2.08%
1 week-4.92%
Current month+1.76%
1 month+4.58%
3 months-17.70%
6 months-20.49%
Current year-30.28%
1 week 3.74
Extreme 3.735
4.06
1 month 3.58
Extreme 3.575
4.1
Current year 3.54
Extreme 3.545
6
1 year 3.54
Extreme 3.545
6.95
3 years 3.54
Extreme 3.545
9.6
5 years 2.6
Extreme 2.605
24.8
10 years 2.6
Extreme 2.605
28.5
Manager TitleAgeSince
Chief Executive Officer 53 02/05/2023
Director of Finance/CFO 56 31/12/2021
Chief Tech/Sci/R&D Officer 50 31/12/2022
Director TitleAgeSince
Chairman 53 02/05/2023
Director/Board Member 70 31/12/2015
Director/Board Member 63 04/03/2020
Date Insider Type Main position Quantity % Market Cap.
09/12/25 Buy

Director

15,000 0.0095%
09/12/25 Sell

Director

15,000 0.0095%
28/11/25 Buy

Director

15,900 0.0101%
Change 5-day change 1-year change 3-year change Capi.($)
-2.08%-4.92%-43.81%-24.25% 63.84M
+0.04%+5.64%-11.58%+12.39% 202B
-0.14%+2.76%+1.16%+14.86% 119B
+1.00%+2.08%+10.66%+78.46% 60.69B
0.00%-6.57%+30.31%+56.72% 52.38B
-0.15%+5.39%-1.41%-30.72% 52.3B
-0.04%+4.08%+21.62%-8.52% 34.85B
+2.10%-0.57% - - 30.06B
-0.77%+1.37%+42.13%-10.31% 24.85B
+1.03%-2.88%-5.22%+24.87% 23.84B
Average +0.06%-0.08%+4.87%+12.61% 60.03B
Weighted average by Cap. +0.16%+1.90%+2.87%+18.31%

Financials

2026 *2027 *
Net sales 128M 13.49M 11.55M 10.81M 9.89M 18.57M 1.29B 18.81M 49.8M 648M 50.64M 49.53M 2.14B 204M 21.54M 18.45M 17.27M 15.81M 29.66M 2.06B 30.05M 79.55M 1.04B 80.89M 79.13M 3.42B
Net income -68.9M -7.28M -6.23M -5.83M -5.34M -10.02M -696M -10.15M -26.87M -350M -27.32M -26.73M -1.16B -36.8M -3.89M -3.33M -3.11M -2.85M -5.35M -372M -5.42M -14.35M -187M -14.59M -14.27M -618M
Net Debt - -
Logo Senzime AB
Senzime AB (publ.) is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.
Employees
59
Date Price Change Volume
24/08/26 SEK 3.765 -2.08% 138,193
21/08/26 SEK 3.845 +0.92% 178,947
20/08/26 SEK 3.810 -0.91% 111,043
19/08/26 SEK 3.845 -4.71% 143,112
18/08/26 SEK 4.035 +1.89% 117,341

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEZI Stock